Prophylaxis regimens for GVHD: systematic review and meta-analysis.
about
Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsExtracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsExtracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsExtracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsExtracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsExtracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsTacrolimus versus cyclosporine A for prevention of graft versus host disease after stem cell transplantationAcute graft-versus-host disease: a bench-to-bedside update.Pathogenesis and management of graft-versus-host disease.Graft-versus-host disease treatment: predictors of survival.Graft-versus-host disease prophylaxis after transplantation: a network meta-analysis.KRE5 Suppression Induces Cell Wall Stress and Alternative ER Stress Response Required for Maintaining Cell Wall Integrity in Candida glabrataCyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease.Pharmacologic prophylaxis regimens for acute graft-versus-host disease: past, present and future.The Nlrp3 inflammasome regulates acute graft-versus-host disease.Immunosuppressive effects of multipotent mesenchymal stromal cells on graft-versus-host disease in rats following allogeneic bone marrow transplantation.Acute graft-versus-host disease: new treatment strategies.Cutaneous graft-versus-host disease: rationales and treatment options.Acute graft-versus-host disease following hematopoietic stem-cell transplantation.New ways to separate graft-versus-host disease and graft-versus-tumour effects after allogeneic haematopoietic stem cell transplantation.Graft versus host disease: clinical evaluation, diagnosis and management.Complications of allogeneic hematopoietic stem cell transplantation.The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter I: current practice and remaining unmet medical needs.Stem cell transplantation for the treatment of immunodeficiency in children: current status and hopes for the future.Novel approaches for preventing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.A randomized controlled trial of cyclosporine and tacrolimus with strict control of blood concentrations after unrelated bone marrow transplantation.Mycophenolate-based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative-related donor stem cell transplantation.Target blood concentrations of CYA and tacrolimus in randomized controlled trials for the prevention of acute GVHD after hematopoietic SCT.Allogeneic hematopoietic stem cell transplantation in pediatric myelodysplastic syndromes: a multicenter experience from Argentina.
P2860
Q24187102-799D8879-2C9E-46F0-8986-00E1A7355ABCQ24187108-89D401CF-BDB3-48D1-B114-0A9597FBD836Q24200272-F0C6766A-1788-43DE-975F-D33F474C896CQ24200282-B69B0487-813B-4A6E-86C3-45DE91942C08Q24200648-6EB20CCC-C559-4B9C-8875-ED8BECE822FAQ24202963-1905F8DC-B612-48CF-A9F3-91FBAF4C565AQ26472072-9EAF4E36-D824-4994-A660-D70C4F518215Q27687130-AFD69984-E3CA-40F2-ADE6-85D36E6121C8Q34077479-632A9F12-CBF9-4B27-B1D7-35B10DAA166BQ34205096-746B51A0-0D2A-4BBF-8DD5-68A1EA973BB4Q35499395-7003C045-C735-4F09-BB56-F8AE90BF0512Q36109051-02E40616-A189-4EF4-AAC4-548916CF9EA7Q36715943-CB88E633-532A-4123-AEBC-1686E5C742B2Q36980277-1390FBC9-A70E-495D-AE48-C4B8480E93F6Q37194967-AE87BC7B-569D-4CB1-B6BF-3AA9C26CFFC6Q37426583-1D15AC79-38F9-4A57-9A64-2F247D22DA5AQ37610714-C0DDC9F9-313B-4797-8B96-80A9613E4C22Q37853600-5E05061E-5304-4533-9F95-6DCE802BE7C9Q37930715-1695D0EA-D792-4BF0-9FA3-F6498F83AA32Q38057376-51016D93-1EFF-40FD-8D9B-714B50289EB5Q38090503-4ACDFD64-640A-496C-9CF6-C16EB5A42736Q38217938-D5885522-6586-4FA3-B9F2-3B9444029C96Q38453666-47A70D41-08C1-407A-B5CC-2E0A29D1F89AQ38735833-2AAAF0F2-A521-47E5-9976-03E923D88DCCQ38816505-D5FAF8FB-71F2-4634-8BA9-FC6C44C5C975Q40966054-B226EF8A-0148-4403-8AA1-CFFA2AC86A18Q41525058-D98453D7-B9FC-41C8-BB8E-08D5DD98F82BQ43287455-3B265964-082A-4ECD-9FBC-CCA3698A4D31Q43737380-A9E6650F-A94E-4BEC-BBC9-C0C2BCC81575
P2860
Prophylaxis regimens for GVHD: systematic review and meta-analysis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Prophylaxis regimens for GVHD: systematic review and meta-analysis.
@en
Prophylaxis regimens for GVHD: systematic review and meta-analysis.
@nl
type
label
Prophylaxis regimens for GVHD: systematic review and meta-analysis.
@en
Prophylaxis regimens for GVHD: systematic review and meta-analysis.
@nl
prefLabel
Prophylaxis regimens for GVHD: systematic review and meta-analysis.
@en
Prophylaxis regimens for GVHD: systematic review and meta-analysis.
@nl
P2093
P2860
P356
P1476
Prophylaxis regimens for GVHD: systematic review and meta-analysis.
@en
P2093
A Gafter-Gvili
M Yeshurun
O Shpilberg
P2860
P2888
P304
P356
10.1038/BMT.2008.373
P407
P50
P577
2008-11-10T00:00:00Z